BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10561909)

  • 1. True small lymphocytic T-cell chronic lymphocytic leukemia lacking the CD3 molecule and TCR-alpha beta on its cell surface.
    Murakami K; Taketazu F; Ida M; Ito K; Yamazaki I; Oshimi K; Kanazawa Y; Kawakami M
    Int J Hematol; 1999 Oct; 70(3):169-73. PubMed ID: 10561909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia.
    Koníková E; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1994; 41(2):69-74. PubMed ID: 8208317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic lymphatic leukemia. Immunophenotyping as an aid to correct diagnosis].
    Ly B; Hammerstrøm J; Bergheim J; Dahl IM; Grøttum KA; Lødemel B; Baklien K; Smeland E
    Tidsskr Nor Laegeforen; 1998 Jan; 118(2):233-7. PubMed ID: 9485618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population.
    Goolsby CL; Kuchnio M; Finn WG; Peterson L
    Cytometry; 2000 Jun; 42(3):188-95. PubMed ID: 10861692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD20-positive T-cell chronic lymphocytic leukaemia.
    Takami A; Saito M; Nakao S; Asakura H; Nozue T; Onoe Y; Yachie A; Shiobara S; Matsuda T
    Br J Haematol; 1998 Sep; 102(5):1327-9. PubMed ID: 9753064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia.
    Nishii K; Katayama N; Mitani H; Matsumoto T; Miwa H; Kita K; Shiku H
    Int J Hematol; 2000 Jan; 71(1):59-65. PubMed ID: 10729995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
    Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
    Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
    Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
    Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous expression of CD2 on a B-cell, small lymphocytic neoplasm.
    Viciana AL; Lancet FC; Chamizo W; Voigt W; Ruiz P
    Cytometry; 1994 Mar; 18(1):42-8. PubMed ID: 7915983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotype of chronic lymphocytic leukemia and prolymphocytic leukemia].
    Maruyama S
    Nihon Rinsho; 1992 Jun; 50(6):1236-40. PubMed ID: 1518139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
    Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
    Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
    Guillaume N; Alimardani G; Capiod JC; Claisse JF
    Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.
    Miyata A; Kojima K; Yoshino T; Fujii S; Shinagawa K; Ichimura K
    Int J Hematol; 2001 Feb; 73(2):230-5. PubMed ID: 11372737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.